Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that it has secured three further orders totalling over $1m in the CBRN detection segment.
This includes two orders in nuclear security, with one order for the further development of the Group’s bio-security technology. The majority of the revenue will be recognised in the current financial year, which helps to underpin forecasts along with the recent $5.9m contract from the US Department of Homeland Security.
Arnab Basu, CEO of Kromek, said: “Geopolitical insecurity, combined with other global threats, continue to drive demand for our products that contribute to ensuring public safety and security. Governments and their agencies buy our products because they are best-of-breed and we have the ability to deploy rapidly. The receipt of orders from existing customers is testament to the strength of our offer and the value of our products to our customers. We are also pleased to have received an order from a new customer that is a substantial, global defence corporation, which we believe represents a significant opportunity for further sales. With the sustained commercial momentum in CBRN, we look forward to receiving further orders in due course.”
Back to Latest
